You just read:

SIMPONI®* I.V. (golimumab) becomes first fully human Anti-TNF infusion therapy approved for treatment of moderately to severely active rheumatoid arthritis

News provided by

Janssen Inc.

Dec 02, 2013, 07:00 ET